Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 19, 2012
- Revision received November 12, 2012
- Accepted November 20, 2012
- Published first December 5, 2012.
Article Versions
- Previous version (December 5, 2012 - 06:28).
- You are currently viewing a Previous version of this article (January 11, 2013 - 09:30).
- View the most recent version of this article
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Joan T. Garrett1,
- Cammie R. Sutton1,
- María Gabriela Kuba2,
- Rebecca S. Cook3,4, and
- Carlos L. Arteaga1,3,4,5
- Authors' Affiliations: Departments of 1Medicine, 2Pathology, and 3Cancer Biology, 4Breast Cancer Research Program, and 5Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
- Corresponding Author:
Carlos L. Arteaga, Division of Oncology/VUMC, Vanderbilt University, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232. Phone: 615-936-3524; Fax: 615-936-1790; E-mail: carlos.arteaga{at}vanderbilt.edu
Published OnlineFirst January 11, 2013
doi: 10.1158/1078-0432.CCR-12-2024
Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function
Jump to section
Advertisement